Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DIETARY_SUPPLEMENT(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04387682Not ApplicableUnknown
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
Squamous Cell Carcinoma of the Oral Cavity
PrincipalinvestigatorStart date: 2017-03-22

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Taiwan University Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael Pogorzelski, Dr.

Universitätsklinikum Essen

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Aftab Mahmood, MD

Cancer Specialists of South Texas, P.A.

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Pardip Pathare, MD

Norwalk Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Christine H. Chung, M.D.

H. Lee Moffitt Cancer Center and Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

wilfried De Neve, MD, PhD

University Hospital, Ghent

Moderately Similar
10 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Andrew Sikora, MD, PhD

Icahn School of Medicine at Mount Sinai

Moderately Similar
3 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Eyal Talor, PhD

CEL-SCI Corporation

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Sanjiv Agarwala, MD

St. Luke's Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Orlando Guntinas-Lichius, Prof. Dr.

Friedrich-Schiller-University Jena

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Douglas Adkins, MD

Washington University School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of the Oral Cavity
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04387682Not ApplicablePrincipalInvestigator

Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients

Squamous Cell Carcinoma of the Oral Cavity
Unknown

All 1 trials loaded